Predictors of neoadjuvant chemotherapy for triple-negative breast cancer: a meta-analysis with 723 cases

By Zhang Guojing   Xie Wanqing   Xu Long   Liu Zhaozhe   Xie Xiaodong  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 1, 2013-01 ,pp. : 15-19

Springer Publishing Company

Access to resources Recommend Favorite

The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis

By Petrelli Fausto   Coinu Andrea   Borgonovo Karen   Cabiddu Mary   Ghilardi Mara   Lonati Veronica   Barni Sandro  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 223-232

Springer Publishing Company

Access to resources Recommend Favorite

Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 257-264

Spandidos Publications

Access to resources Recommend Favorite

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients

By Masuda Hiroko   Masuda Norikazu   Kodama Yoshinori   Ogawa Masami   Karita Michiko   Yamamura Jun   Tsukuda Kazunori   Doihara Hiroyoshi   Miyoshi Shinichiro   Mano Masayuki   Nakamori Shoji   Tsujinaka Toshimasa  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 911-917

Springer Publishing Company

Access to resources Recommend Favorite

Platinum-based therapy for triple-negative breast cancer treatment: A meta-analysis

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 720-724

Science Publishers

Access to resources Recommend Favorite